Diagram B.V.   Report issue

For profit Phase 2 Phase 4
Founded: Zwolle Netherlands (1996)

Organization Overview

First Clinical Trial
2014
NCT02118870
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Diagram B.V.

Active Ingredients

Drugs in Phase 4 Trials (3)

acetylsalicylic acid (aspirin) (2 trials)

clopidogrel (plavix) (2 trials)

ticagrelor (brilinta) (1 trial)

Drugs in Phase 2 Trials (1)

Zalunfiban (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Coronary Disease (Phase 2)

Heart Diseases (Phase 2)

Infarction (Phase 2)

Myocardial Infarction (Phase 2)

ST Elevation Myocardial Infarction (Phase 2)

Syndrome (Phase 4)

Vascular Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4